Yuka Inoue

952 citations

33 papers · 569 indexed · h-index 14

Co-authors: Shoichi Hazama Yoshihiko Maehara Nami Yamashita Eiji Oki Eriko Tokunaga Kimihiro Tanaka Hiroshi Saeki Hiroyuki Kitao
Topics: Cancer Immunotherapy and Biomarkers (5 papers)Immunotherapy and Immune Responses (5 papers)Metastasis and carcinoma case studies (4 papers)
Cited by: Oncology Cancer Research Immunology
Journals: Journal of Clinical Oncology PLoS ONE Cancer Science
Partner nations: Japan United States Oman

In The Last Decade

Yuka Inoue

30 papers receiving 565 citations

Peers

Countries citing papers authored by Yuka Inoue

Since Specialization

Citations

This map shows the geographic impact of Yuka Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuka Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuka Inoue more than expected).

Fields of papers citing papers by Yuka Inoue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuka Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuka Inoue. The network helps show where Yuka Inoue may publish in the future.

Co-authorship network of co-authors of Yuka Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Yuka Inoue. A scholar is included among the top collaborators of Yuka Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuka Inoue. Yuka Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer 2018 ·Clinical Breast Cancer ·Nami Yamashita,Eriko Tokunaga,Makoto Iimori,Yuka Inoue,Kimihiro Tanaka,Hiroyuki Kitao,Hiroshi Saeki,Eiji Oki,Yoshihiko Maehara	64
2	The Clinical Usefulness of the LigaSure™ Small Jaw in Axillary Lymph Node Dissection in Patients with Breast Cancer 2018 ·Anticancer Research ·Yuka Inoue,Nami Yamashita,Hiroki Ueo,Kimihiro Tanaka,Hiroshi Saeki,Eiji Oki,Eriko Tokunaga,Yoshihiko Maehara	6
3	Surgical Resection and Outcome of Synchronous and Metachronous Primary Lung Cancer in Breast Cancer Patients 2017 ·Anticancer Research ·Fumihiro Shoji,Nami Yamashita,Yuka Inoue,Yuka Kozuma,Gouji Toyokawa,Fumihiko Hirai,Kensaku Ito,Tetsuzo Tagawa,Tatsuro Okamoto,Yoshihiko Maehara	2
4	The Local Recurrence of Breast Cancer with Squamous Metaplasia and Obvious Histological Heterogeneity 2017 ·Anticancer Research ·Nami Yamashita,Eriko Tokunaga,Hidetaka Yamamoto,Chikako Shimizu,Kenji Taketani,Yuka Inoue,Hiroshi Saeki,Eiji Oki,Yoshihiko Maehara	0
5	A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancer 2017 ·Breast Cancer ·Shigeru Yamamoto,Noriko Maeda,Yukiko Nagashima,(unknown),Yoko Sato,Hiroto Matsui,Yuka Inoue,Yoshitaro Shindo,Shinsuke Kanekiyo,Kazuhiko Sakamoto,Nobuaki Suzuki,Shigeru Takeda,Tomio Ueno,Shigefumi Yoshino,Shoichi Hazama,Masaaki Oka,(unknown)	11
6	Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer 2017 ·Clinical Breast Cancer ·Yuka Inoue,Nami Yamashita,Hiroyuki Kitao,Kimihiro Tanaka,Hiroshi Saeki,Eiji Oki,Yoshinao Oda,Eriko Tokunaga,Yoshihiko Maehara	7
7	Characterization of the T cell repertoire by deep T cell receptor sequencing in tissues and blood from patients with advanced colorectal cancer 2016 ·Oncology Letters ·Kenji Tamura,Shoichi Hazama,Rui Yamaguchi,Seiya Imoto,Hiroko Takenouchi,Yuka Inoue,Shinsuke Kanekiyo,Yoshitaro Shindo,Satoru Miyano,Yusuke Nakamura,Kazuma Kiyotani	34
8	MicroRNA-6826 and −6875 in plasma are valuable non-invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer 2016 ·Oncology Reports ·(unknown),Shoichi Hazama,Ryouichi Tsunedomi,Hironori Tanaka,Hiroko Takenouchi,Shinsuke Kanekiyo,Yuka Inoue,(unknown),Michihisa Iida,Kazuhiko Sakamoto,Nobuaki Suzuki,Shigeru Takeda,Tomio Ueno,Shigeru Yamamoto,Shigefumi Yoshino,Kiyotaka Okuno,Hiroaki Nagano	33
9	Impact of Expression of Vimentin and Axl in Breast Cancer 2016 ·Clinical Breast Cancer ·Kimihiro Tanaka,Eriko Tokunaga,Yuka Inoue,Nami Yamashita,Hiroshi Saeki,Shinji Okano,Hiroyuki Kitao,Eiji Oki,Yoshinao Oda,Yoshihiko Maehara	37
10	Prediction of the efficacy of immunotherapy by measuring the integrity of cell‐free DNA in plasma in colorectal cancer 2016 ·Cancer Science ·(unknown),Shoichi Hazama,Ryouichi Tsunedomi,Hiroko Takenouchi,Shinsuke Kanekiyo,Yuka Inoue,Masao Nakajima,Shinobu Tomochika,Yoshihiro Tokuhisa,Michihisa Iida,Kazuhiko Sakamoto,Nobuaki Suzuki,Shigeru Takeda,Tomio Ueno,Shigeru Yamamoto,Shigefumi Yoshino,(unknown)	23
11	Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer 2015 ·The Breast ·Eriko Tokunaga,Nami Yamashita,Hiroyuki Kitao,Kimihiro Tanaka,Kenji Taketani,Yuka Inoue,Hiroshi Saeki,Eiji Oki,Yoshinao Oda,Yoshihiko Maehara	6
12	Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer 2015 ·Clinical Breast Cancer ·Nami Yamashita,Eriko Tokunaga,Hiroyuki Kitao,Megan P. Hitchins,Yuka Inoue,Kimihiro Tanaka,Yuichi Hisamatsu,Kenji Taketani,Sayuri Akiyoshi,Satoko Okada,Yoshinao Oda,Hiroshi Saeki,Eiji Oki,Yoshihiko Maehara	43
13	Prevention of the exposure by cyclophosphamide oral tablet 2015 ·Journal of Pharmaceutical Health Care and Sciences ·(unknown),Yoichiro Takami,K. Moriyama,(unknown),(unknown),(unknown),Yuka Inoue,(unknown),(unknown),(unknown),(unknown),Atsuko Yamamoto,Kenichi Shimada,Masashi Takahashi,Takashi Egawa	5
14	A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes 2014 ·International Journal of Oncology ·Ryouichi Tsunedomi,Shoichi Hazama,Yusuke Fujita,Naoko Okayama,Shinsuke Kanekiyo,Yuka Inoue,Shigefumi Yoshino,Takahiro Yamasaki,(unknown),Koji Oba,Hideyuki Mishima,Junichi Sakamoto,Yoshihiko Hamamoto,Makoto Oka	13
15	FcγR and EGFR Polymorphisms as Predictive Markers of Cetuximab Efficacy in Metastatic Colorectal Cancer 2014 ·Molecular Diagnosis & Therapy ·Yuka Inoue,Shoichi Hazama,Shigeyoshi Iwamoto,(unknown),Chu Matsuda,Ryouichi Tsunedomi,Naoko Okayama,Yuji Hinoda,Takahiro Yamasaki,Yutaka Suehiro,Shigefumi Yoshino,Junichi Sakamoto,Hideyuki Mishima,Masaaki Oka	9
16	A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome 2014 ·Journal of Translational Medicine ·Shoichi Hazama,Yusuke Nakamura,Hiroko Takenouchi,Nobuaki Suzuki,Ryouichi Tsunedomi,Yuka Inoue,Yoshihiro Tokuhisa,Norio Iizuka,Shigefumi Yoshino,Kazuyoshi Takeda,Hirokazu Shinozaki,Akira Kamiya,Hiroyuki Furukawa,Masaaki Oka	66
17	UGT1A16,1A73, and 1A922* genotypes predict severe neutropenia in FOLFIRI‐treated metastatic colorectal cancer in two prospective studies in Japan 2013 ·Cancer Science ·Shoichi Hazama,Hideyuki Mishima,Ryouichi Tsunedomi,Yusuke Okuyama,Takeshi Kato,Keníchi Takahashi,Hiroshi Nozawa,Hideaki Ando,Michiya Kobayashi,Hiroyoshi Takemoto,Naoki Nagata,Shinsuke Kanekiyo,Yuka Inoue,Yoshihiko Hamamoto,Yusuke Fujita,Yuji Hinoda,Naoko Okayama,Koji Oba,Junichi Sakamoto,Masaaki Oka	27
18	Usefulness of endoscopic breast-conserving surgery for breast cancer 2013 ·Surgery Today ·Hiroki Takahashi,Teruhiko Fujii,Shino Nakagawa,Yuka Inoue,(unknown),Uhi Toh,Nobutaka Iwakuma,Ryuji Takahashi,Miki Takenaka,Eisuke Fukuma,Kazuo Shirouzu	18
19	MR imaging of malignant primary breast lymphoma: including diffusion-weighted imaging, histologic features, and a literature review 2013 ·Japanese Journal of Radiology ·Roka Namoto Matsubayashi,Yuka Inoue,Seiichi Okamura,Seiya Momosaki,Takahiko Nakazono,Toru Muranaka	10
20	A CASE OF A RAPIDLY WORSENING MALIGNANT PHYLLODES TUMOR WITH AXILLARY LYMPH NODE METASTASIS 2009 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Hiroki Takahashi,(unknown),Yuka Inoue,Masakazu Katsura,(unknown),Teruhiko Fujii	0

About Yuka Inoue

Yuka Inoue is a scholar working on Oncology, Cancer Research and Occupational Therapy, having authored 33 papers that have together received 569 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and Metastasis and carcinoma case studies (4 papers). The work is most often cited by research in Oncology (353 citations), Cancer Research (157 citations) and Immunology (163 citations). Yuka Inoue has collaborated with scholars based in Japan, United States and Oman. Frequent co-authors include Shoichi Hazama, Yoshihiko Maehara, Nami Yamashita, Eiji Oki, Eriko Tokunaga, Kimihiro Tanaka, Hiroshi Saeki, Hiroyuki Kitao, Ryouichi Tsunedomi and Masaaki Oka. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact